| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 03/22/2011 | US7910563 Antisense oligonucleotide to inhibit melanoma inhibitory activity, MIA |
| 03/22/2011 | US7910562 Method of delivering genes into antigen presenting cells of the skin |
| 03/22/2011 | US7910551 Gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 03/22/2011 | US7910370 Treating and preventing cell proliferative, neurodegenerative and viral infections via enhancing oncogenic protein expression |
| 03/22/2011 | US7910320 Methods compositions and compound assays for inhibiting amyloid-beta protein production |
| 03/22/2011 | US7910297 Modified aptmer for use in selective treatment and prevention of infection and cell proliferative disorders |
| 03/22/2011 | US7910093 administering to mammals a Sindbis virus comprising gene that code detectable labels, concurrently with anticarcinogenic agents, and analyzing the amount of cancer cells in the body of the mammal |
| 03/22/2011 | CA2480273C Ph-sensitive polymer |
| 03/22/2011 | CA2461380C Hepatitis c virus vaccine |
| 03/22/2011 | CA2412050C A recombinant non-replicating virus expressing gm-csf and uses thereof to enhance immune responses |
| 03/22/2011 | CA2308127C Agonist and antagonist peptides of carcinoembryonic antigen (cea) |
| 03/22/2011 | CA2264483C Method for recombinant adeno-associated virus-directed gene therapy |
| 03/22/2011 | CA2236159C Vp antigens of the jc virus |
| 03/17/2011 | WO2011032180A1 Oncolytic vaccinia virus combination cancer therapy |
| 03/17/2011 | WO2011031482A2 Treatment of 'iq motif containing gtpase activating protein' (iqgap) related diseases by inhibition of natural antisense transcript to iqgap |
| 03/17/2011 | WO2011030334A1 Compositions and methods for treatment, diagnosis and prognosis of mesothelioma |
| 03/17/2011 | WO2011030312A1 NOVEL INHIBITORS OF STEAROYL-CoA-DESATURASE-1 AND THEIR USES |
| 03/17/2011 | WO2011011631A3 Nucleic acid delivery vehicles |
| 03/17/2011 | US20110065908 Methods and compositions for the specific inhibition of gene expression by double-stranded rna |
| 03/17/2011 | US20110065773 Rna interference mediating small rna molecules |
| 03/17/2011 | US20110065770 Formulations comprising antisense nucleotides to connexins |
| 03/17/2011 | US20110065650 Methods of Inhibiting Tumor Cell Proliferation |
| 03/17/2011 | US20110065636 Screening and Therapy for Lymphatic Disorders Involving the FLT4 Receptor Tyrosine Kinase (VEGFR-3) |
| 03/17/2011 | US20110065179 Transgene delivering retrovirus targeting collagen exposed at site of tissue injury |
| 03/17/2011 | US20110065173 Vector |
| 03/17/2011 | US20110065147 Methods and reagents for modulating cholesterol levels |
| 03/17/2011 | US20110065146 Expression of HIV polypeptides and production of virus-like particles |
| 03/17/2011 | US20110065118 Drug Screening Using Islet Cells and Islet Cell Progenitors from Human Embryonic Stem Cells |
| 03/17/2011 | US20110065109 Rna interference mediating small rna molecules |
| 03/17/2011 | US20110064817 Continuous multi-microencapsulation process for improving the stability and storage life of biologically active ingredients |
| 03/17/2011 | US20110064770 Immunization of an Individual Against Carcinomas and the Preliminary Stages Thereof |
| 03/17/2011 | US20110064759 Method for the Identification of Extracellular Domains of Epstein Barr Virus (EBV) Tumor-Associated Latent Membrane Proteins and for the Selection of Antibody Reagents Reactive Therewith |
| 03/17/2011 | US20110064734 Prevention and treatment of amyloidogenic disease |
| 03/17/2011 | US20110064701 Pluripotent embryonic-like stem cells, compositions, methods and uses thereof |
| 03/17/2011 | US20110064689 In situ immunization |
| 03/17/2011 | CA2774144A1 Oncolytic vaccinia virus combination cancer therapy |
| 03/17/2011 | CA2771172A1 Treatment of 'iq motif containing gtpase activating protein' (iqgap) related diseases by inhibition of natural antisense transcript to iqgap |
| 03/16/2011 | EP2295606A1 Expression analysis of KIAA nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| 03/16/2011 | EP2295604A2 Diagnosis and treatment of cancers with microRNA located in or near cancer-associated chromosomal features |
| 03/16/2011 | EP2295598A1 Method and kit for detection of cancer, and therapeutic agent for cancer |
| 03/16/2011 | EP2295588A1 Novel artificial antigen presenting cells and uses thefor |
| 03/16/2011 | EP2295578A2 Cyp1b1 nucleic acids and methods of use |
| 03/16/2011 | EP2295456A1 Albumin fusion proteins |
| 03/16/2011 | EP2295441A2 Novel Bicyclonucleoside and Oligonucleotide Analogue |
| 03/16/2011 | EP2295084A1 Targeted gene delivery to non-phagocytic mammalian cells via bacterially derived intact minicells |
| 03/16/2011 | EP2295074A1 Anti-neovasculature preparations for treating cancer |
| 03/16/2011 | EP2295065A1 Modified heat shock protein-antigenic peptide complex |
| 03/16/2011 | EP2294918A1 Use of a ribonuclease of the T2 family having actin-binding activity for inhibiting and/or reversing proliferation |
| 03/16/2011 | EP2294195A1 Oligonucleotide duplexes comprising dna-like and rna-like nucleotides and uses thereof |
| 03/16/2011 | EP2097453B1 Monoclonal antibodies against the human anti-müllerian hormone type ii receptor (amhr-ii) |
| 03/16/2011 | EP1694361B1 Targeted gene delivery to non-phagocytic mammalian cells via bacterially derived intact minicells |
| 03/16/2011 | EP1641926B1 Therapeutic use of lpi, a staphylococcal lectin pathway inhibitor in inflammatory diseases |
| 03/16/2011 | CN1769433B Recombinant vesicular stomatitis virus and its uses |
| 03/16/2011 | CN101985610A Salmonella typhi ghost, preparation method and application thereof serving as delivery system |
| 03/16/2011 | CN101985037A Applications of receptor for activated C-kinase 1 as target against tumor drug-resistance |
| 03/16/2011 | CN101407815B Use of glycine-N-methyltransferase (GNMT) in preparing medicine for preventing and treating disease derived from flavacin |
| 03/15/2011 | US7908087 Methods of identifying latent splice sites |
| 03/15/2011 | US7906638 Chimeric nucleic acids encoding polypeptides comprising CD70 and Fas ligand domains |
| 03/15/2011 | US7906620 Tumor associated antigen, peptides thereof, and use of same as anti-tumor vaccines |
| 03/15/2011 | US7906616 Truncated DANCE, DANCE complex and method of using these |
| 03/15/2011 | US7906331 Methods for identifying stem cells expressing breast cancer resistance protein (BCRP) |
| 03/15/2011 | US7906312 Viral vectors whose replication and, optionally, passenger gene are controlled by a gene switch activated by heat in the presence or absence of a small-molecule regulator |
| 03/15/2011 | US7906113 DNA viral vector comprising nucleotide seuences coding modified capsid protein for use in enhancement of heterologous gene transfer; improved exogenous gene expression |
| 03/15/2011 | US7906111 Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses therefor |
| 03/15/2011 | CA2494063C Inhibition of proliferation and infiltration of brain tumor cells caused by expression of ampa-type glutamate receptor subunit |
| 03/15/2011 | CA2452005C Inhibition of apoptosis process and improvement of cell performance |
| 03/15/2011 | CA2338982C Bpc-1: a secreted brain specific protein expressed and secreted by prostate and bladder cancer cells |
| 03/15/2011 | CA2188422C Bifunctional protein, preparation and use |
| 03/10/2011 | WO2011028890A2 Compositions and methods for treatment of neuropathic pain |
| 03/10/2011 | WO2011028847A1 Polyvalent polynucleotide nanoparticle conjugates as delivery vehicles for a chemotherapeutic agent |
| 03/10/2011 | WO2011028660A1 Compositions for inhibiting growth of cancer stem cells |
| 03/10/2011 | WO2011027829A1 Composition containing rna derived from lactic acid bacterium as active ingredient |
| 03/10/2011 | WO2011027807A1 Immunity inducer |
| 03/10/2011 | WO2011026185A1 An assay for monitoring a neurological condition |
| 03/10/2011 | WO2011018672A8 Methods and substances for stimulating muscle regeneration |
| 03/10/2011 | WO2011008348A3 Dual vector for inhibition of human immunodeficiency virus |
| 03/10/2011 | WO2010130418A3 Treatment of eye diseases using encapsulated cells encoding and secreting a neuroprotective factor and/or an anti-angiogenic factor |
| 03/10/2011 | WO2010126246A3 ANTI ErbB2 RNA APTAMER AND APPLICATIONS THEREFOR |
| 03/10/2011 | WO2010108657A3 C5a binding nucleic acids and the use thereof |
| 03/10/2011 | US20110061120 Self-cleaving ribozymes and uses thereof |
| 03/10/2011 | US20110060034 Cell transdifferentiation into brown adipocytes |
| 03/10/2011 | US20110060032 Lipid encapsulating interfering rna |
| 03/10/2011 | US20110060027 Aptamer Therapeutics Useful in the Treatment of Complement-Related Disorders |
| 03/10/2011 | US20110060014 Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents |
| 03/10/2011 | US20110059901 Compositions and Methods for Treatment of Neoplastic Disease |
| 03/10/2011 | US20110059899 Kruppel-like factor 6 (KLF6), a tumor suppressor protein, and diagnostics, therapeutics, and screening based on this protein |
| 03/10/2011 | US20110059896 Use of furin convertase inhibitors in the treatment of fibrosis and scarring |
| 03/10/2011 | US20110059531 Method for expression of small rna molecules within a cell |
| 03/10/2011 | US20110059067 Modulation of oligonucleotide cpg-mediated immune stimulation by positional modification of nucleosides |
| 03/10/2011 | US20110059056 Method for the Generation of Genetically Modified Vertebrate Precursor Lymphocytes and Use Thereof for the Production of Heterologous Binding Proteins |
| 03/10/2011 | US20110059015 Vaccine |
| 03/10/2011 | CA2773083A1 Immunity-inducing agent |
| 03/09/2011 | EP2292780A2 Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses thereof |
| 03/09/2011 | EP2292779A2 Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses thereof |
| 03/09/2011 | EP2292778A1 Use of lentiviral triplex forming sequences for nuclear transfer of nucleotide sequences |
| 03/09/2011 | EP2292772A1 HIV vaccination with a DNA encoding a HIV polypeptide and a HIV polypeptide |
| 03/09/2011 | EP2292771A2 Sense mRNA therapy |
| 03/09/2011 | EP2292757A2 Treatment of eye disorders characterized by an elevated intraocular pressure by siRNAs |
| 03/09/2011 | EP2292734A1 Hematopoietic cells from human embryonic stem cells |
| 03/09/2011 | EP2292634A2 Nucleic acid sequences encoding and compositions comprising IgE signal peptide and/or IL-15 and methods for using the same |